Publishing research using ab120182? Please let us know so that we can cite the reference in this datasheet.

ab120182 has been referenced in 1 publication.

  • York B  et al. Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD. Sci Rep 7:11793 (2017). PubMed: 28924233

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE, NOT FOR USE IN HUMANS"

Sign up